نتائج البحث - "Franck Morschhauser"

101

Potential role of tocilizumab in severe gastrointestinal barrier damage after CAR T-cell therapy

المؤلفون: Boualem Sendid, Ibrahim Yakoub-Agha, Marie Lamiaux, Suman Mitra, David Beauvais, Anne-Sophie Moreau, Rémy Nyga, Franck Morschhauser, Oriane Karleskind, Séverine Loridant

المساهمون: Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Institut de Pathologie [CHU Lille], Pôle de Biologie Pathologie Génétique [CHU Lille], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Unité de Glycobiologie Structurale et Fonctionnelle UMR 8576 (UGSF), Université de Lille-Centre National de la Recherche Scientifique (CNRS), Service de Parasitologie-Mycologie [CHRU LIlle], Institut de Microbiologie [CHRU Lille], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Pôle de Biologie Pathologie Génétique [CHU Lille], Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Miniaturisation pour la Synthèse, l’Analyse et la Protéomique - UAR 3290 (MSAP), Institute for Translational Research in Inflammation - U 1286 (INFINITE (Ex-Liric)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Université de Lille, LillOA

المصدر: Journal of Microbiology, Immunology and Infection, Vol 54, Iss 2, Pp 327-330 (2021)
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 54 (2), pp.327-330. ⟨10.1016/j.jmii.2021.02.006⟩

مصطلحات موضوعية: 0301 basic medicine, Microbiology (medical), musculoskeletal diseases, Il-6, [SDV]Life Sciences [q-bio], Antigens, CD19, 030106 microbiology, Chromosomal translocation, CAR T-cell, Antibodies, Monoclonal, Humanized, Immunotherapy, Adoptive, Microbiology, 03 medical and health sciences, chemistry.chemical_compound, tocilizumab, 0302 clinical medicine, Tocilizumab, Intestinal mucosa, Sepsis, Humans, Immunology and Allergy, Medicine, 030212 general & internal medicine, Intestinal Mucosa, Interleukin 6, skin and connective tissue diseases, Aged, General Immunology and Microbiology, biology, Interleukin-6, business.industry, Candidiasis, General Medicine, Disseminated Candidiasis, QR1-502, [SDV] Life Sciences [q-bio], Gastrointestinal Tract, Intestines, Infectious Diseases, chemistry, Immunology, biology.protein, Gastrointestinal barrier, CAR T-cell therapy, Female, business, Wound healing

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1b97c65438c7652707976da347710ce
http://www.sciencedirect.com/science/article/pii/S1684118221000499

View record from ScienceDirect

Full Text via ClinicalKey

102

Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials

المساهمون: Clinical Haematology

المصدر: Blood Adv
Blood advances, 5(6), 1737-1745. American Society of Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2487154e17618914d7a8232b346eec1a
https://doi.org/10.1182/bloodadvances.2020002724

Full Text via ClinicalKey

103

Angioimmunoblastic T‐cell Lymphoma

المؤلفون: Jehan Dupuis, Franck Morschhauser

المصدر: The Peripheral T-Cell Lymphomas

مصطلحات موضوعية: Chemotherapy, Angioimmunoblastic T-cell lymphoma, business.industry, medicine.medical_treatment, Cancer research, medicine, Risk factor, medicine.disease, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::be133edd4cb280f250b1b4ce12f0fde1
https://doi.org/10.1002/9781119671336.ch9

104

A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma

المساهمون: Hematology

المصدر: Blood, 137(5), 600-609. American Society of Hematology
Blood

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ae5b032ae11d17b10939b5f59777af
https://doi.org/10.1182/blood.2020006578

105

ABCL-073 Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results From the Phase III POLARIX Study

المصدر: Clinical Lymphoma Myeloma and Leukemia. 22:S358-S359

مصطلحات موضوعية: Cancer Research, Oncology, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6ca4314846454a303afd715a7500402e
https://doi.org/10.1016/s2152-2650(22)01498-7

View record from ScienceDirect

Full Text via ClinicalKey

106

End of induction positron emission tomography complete response (PET-CR) as a surrogate for progression-free survival in previously untreated follicular lymphoma

المؤلفون: Jesse G. Dixon, Natalie Dimier, Tina Nielsen, Jamie Zheng, Robert Marcus, Franck Morschhauser, Andrew M. Evens, Massimo Federico, Kristie A. Blum, Qian Shi

المساهمون: Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)

المصدر: British Journal of Haematology
British Journal of Haematology, 2022, British Journal of Haematology, 198 (2), pp.333-337. ⟨10.1111/bjh.18217⟩

مصطلحات موضوعية: previously untreated, [SDV]Life Sciences [q-bio], Remission Induction, PET-CR, Hematology, follicular lymphoma, progression-free survival, surrogate end-point, Disease-Free Survival, Progression-Free Survival, Fluorodeoxyglucose F18, Positron-Emission Tomography, Antineoplastic Combined Chemotherapy Protocols, Humans, Lymphoma, Follicular, Biomarkers, Randomized Controlled Trials as Topic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::444af6fdb6dec3a86f16a572ed19162b
https://pubmed.ncbi.nlm.nih.gov/35491747

View record at Wiley

107

Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials

المؤلفون: Jesse G. Dixon, Çağlar Çağlayan, Dai Chihara, Tina Nielsen, Natalie Dimier, Jamie Zheng, Anna K. Wall, Gilles Salles, Franck Morschhauser, Robert Marcus, Michael Herold, Eva Kimby, Kristie A. Blum, Michele Ghielmini, Qian Shi, Christopher R. Flowers

المصدر: Clinical lymphoma, myelomaleukemia. 22(11)

مصطلحات موضوعية: Male, Cancer Research, Hemoglobins, Oncology, Antineoplastic Combined Chemotherapy Protocols, Humans, Antineoplastic Agents, Hematology, Rituximab, Lymphoma, Follicular, Survival Analysis, Randomized Controlled Trials as Topic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17980184b294c49a394ba65721061987
https://pubmed.ncbi.nlm.nih.gov/36045021

View record from ScienceDirect

Full Text via ClinicalKey

108

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

المؤلفون: Michael R. Bishop, Michael Dickinson, Duncan Purtill, Pere Barba, Armando Santoro, Nada Hamad, Koji Kato, Anna Sureda, Richard Greil, Catherine Thieblemont, Franck Morschhauser, Martin Janz, Ian Flinn, Werner Rabitsch, Yok-Lam Kwong, Marie J. Kersten, Monique C. Minnema, Harald Holte, Esther H.L. Chan, Joaquin Martinez-Lopez, Antonia M.S. Müller, Richard T. Maziarz, Joseph P. McGuirk, Emmanuel Bachy, Steven Le Gouill, Martin Dreyling, Hideo Harigae, David Bond, Charalambos Andreadis, Peter McSweeney, Mohamed Kharfan-Dabaja, Simon Newsome, Evgeny Degtyarev, Rakesh Awasthi, Christopher del Corral, Giovanna Andreola, Aisha Masood, Stephen J. Schuster, Ulrich Jäger, Peter Borchmann, Jason R. Westin

المساهمون: Hematology, Clinical Haematology, CCA - Cancer Treatment and Quality of Life

المصدر: New England Journal of Medicine, 386(7), 629-639. Massachussetts Medical Society
New England journal of medicine, 386(7), 629-639. Massachussetts Medical Society
Bishop, M R, Dickinson, M, Purtill, D, Barba, P, Santoro, A, Hamad, N, Kato, K, Sureda, A, Greil, R, Thieblemont, C, Morschhauser, F, Janz, M, Flinn, I, Rabitsch, W, Kwong, Y-L, Kersten, M J, Minnema, M C, Holte, H, Chan, E H L, Martinez-Lopez, J, Müller, A M S, Maziarz, R T, McGuirk, J P, Bachy, E, Gouill, S L, Dreyling, M, Harigae, H, Bond, D, Andreadis, C, McSweeney, P, Kharfan-Dabaja, M, Newsome, S, Degtyarev, E, Awasthi, R, del Corral, C, Andreola, G, Masood, A, Schuster, S J, Jäger, U, Borchmann, P & Westin, J R 2022, ' Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma ', New England Journal of Medicine, vol. 386, no. 7, pp. 629-639 . https://doi.org/10.1056/NEJMoa2116596

مصطلحات موضوعية: Adult, Male, Salvage Therapy, Cancer Research, Receptors, Chimeric Antigen, Hematopoietic Stem Cell Transplantation, Receptors, Antigen, T-Cell, General Medicine, Middle Aged, Combined Modality Therapy, Immunotherapy, Adoptive, Transplantation, Autologous, Progression-Free Survival, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Lymphoma, Large B-Cell, Diffuse, Aged